The Auxiliary Effect of Artificial Intelligence in the Detection of Precancerous Lesions in Proximal Colon Cancer
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorLimian Er
About this trial
The investigators conducted a multicenter randomized controlled trial to explore the adjuvant effect of artificial intelligence in the detection of precancerous lesions in the proximal colon.This is a prospective, multicenter, single-blind, parallel randomized controlled trial.During the colonoscopy retraction process, the investigators aimed to compare the detection rates of proximal colon adenomas with and without the assistance of an AI(Artificial Intelligence) diagnostic device.
Eligibility criteria
Qualifiers
None
Disqualifiers
Those with inflammatory bowel disease, colorectal cancer and surgical history, as well as those with familial polyposis syndrome
Those with intestinal obstruction or malignant tumors
Patients with colorectal lesions that need to be treated in stages.
Other contraindications for colonoscopy examination.
Trial design
Treatments tested in this trial
- AI group
- Serial group
- Standard colonoscopy group
Treatment groups
1,200 Participants
are divided into 3 treatment groupsSponsors and collaborators
Limian Er
Lead sponsor
Hebei Medical University Fourth Hospital
Sponsor institution
Source ClinicalTrials.gov